Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: The question of cost is cited in the final line of the story, which suggests that the scoring system can “address escalating health care cost issues.” But we didn’t think that was specific enough to warrant a Satisfactory score. The story doesn’t clue readers in to the fact that the financial burden can be measured in billions of dollars — a single screening test recommended for millions of Americans can cost thousands of dollars apiece. The other cost issue specific to this test is that it takes valuable time for providers to retrieve a reputable risk calculator when sitting with a patient and enter in the specific data points, including in this case waist circumference, which clinicians often do not measure as a ‘vital sign’ per se. The story cites a study that credits colonoscopy with reducing the risk of death from colon cancer by about 50 percent, by removing polyps. It would have been helpful for the story to explain what that relative reduction in risk means in absolute terms (e.g. did the rate of cancer death go from 50% to 25% or from 2% to around 1%?) The story also notes that the study found that patients with a low to intermediate risk score “still have a risk between of between 1.9 percent to 9.9 percent of harboring a polyp that can develop into cancer.” We’ll give credit here for the story’s provision of these key statistics, which do give a sense as how well the test accurately identifies truly low-risk individuals. However, we’d note that the benefit here should ideally refer to the ability of the algorithm to classify people at all risk levels (including high-risk), and therefore target the highest-risk patients for colonoscopy. The story doesn’t really get into discussion of the predictive power of the test, referred to as a likelihood ratio, which is in the study manuscript. However, this is a difficult concept for most health care providers and patients, and we think it’s understandable that the story did not include a full discussion of this topic. The harm of a screening test such as this really is “getting it wrong” in terms of predicting someone to be at low risk and finding them to have a higher risk polyp or malignancy. As noted above, the story cautions that “low- to intermediate-risk patients still have a risk between of between 1.9 percent to 9.9 percent of harboring a polyp that can develop into cancer.” This story accurately explains that the research was about predictive modeling, and explains the components of the risk score as well as the study design. There are some cautionary notes in the text, including a statement from outside expert that “the data from this study is not strong enough to spur any changes in current screening recommendations,” an opinion shared by an editorialist on the study. We think this is sufficient for a Satisfactory rating. The story does not hype the incidence or seriousness of the disease. The prevalence statistics cited are consistent with these National Cancer Institute figures. The story contains two independent voices. The perspective they provide is a particular strength of the article. We wish that more stories would reach out to experts not affiliated with the studies being reported on for context. The story notes that a variety of screening tests exist, but the relevant alternative here is actually other risk calculators, which the authors of the study describe and cite but are not routinely used. The story doesn’t mention these other calculators and why they are seldom used — context that would have deepened reader understanding of the issue. Although availability isn’t explicitly addressed, this risk calculator is now available (implicitly) by virtue of publication of the paper. It is a simple scoring system that can be implemented based on the information in the paper, and the story makes this clear. We’ll rate this Satisfactory. The story makes it sound as if this is a first-of-its-kind tool. However, risk calculation tools for colon cancer have been in circulation for many years. We could not find a news release related to this study. But in any case, the comments from two independent experts assure us that the story wasn’t based on a news release.
[EX A]: 'Scoring System' May Spot Those in Greatest Need of Colonoscopy; But one expert cautions that even 'low risk' patients can still develop suspicious polyps

[EX Q]: While there was no mention of coffee cost, this element is not particulary germane to this story. The article reported that drinking four eight-ounce cups of coffee was linked to a 30% reduction in the risk of developing diabetes. Rather than relative reduction, the article should have included the absolute reduction. The rate at which women who drank coffee developed type II diabetes was 6.05% while the rate in women who drank 4-5 cups of coffee per day was 4.30%. The relative difference always sounds more convincing; the absolute difference is what is probably most meaningful to viewers. So, in this case, a 30% relative difference equated to an absolute difference of less than 2%. There was no mention of potential harms that might be derived from increased coffee consumption. The article could have included concern about disrupted sleep, heart palpitations, increased urinary frequency, and jitteriness. Because of the design of the study covered in this story (a prospective epidemiologic study), it is not possible to conclude that increasing decaffeinated coffee consumption will decrease the risk of type II diabetes. This important point was covered by one of the physician quotes in the story. The speculation about what was in decaf coffee that resulted in the decreased risk of type II diabetes was not well grounded. Other than painting perhaps a little too rosy picture of all the potential benefits that might be gained from coffee consumption, this article did not practice disease mongering. It did not present any data on the prevalence of type II diabetes. The story could have mentioned that the Type II diabetes has become rather common place and is a public health issue. It appears that this story is based on a research study in the Archives of Internal Medicine and from comments by one physician and one researcher. It certainly would have been better to actually mention where the study was published rather than referring to it as “the study out today”. It would also have been better to give us some perspective about the value of the quotes provided by giving some background on the two people interviewed. Nonethless, we credit the story for having different perspectives. There was no mention of other lifestyle strategies that an individual might pursue in order to lower the risk of type II diabetes. This is a particularly important public health message. Moderate daily physical activity, such as walking, has also been shown to lower the risk of type II diabetes. The story isn’t about a treatment per se, but about the effects of drinking coffee, which is readily available to all. The story is quite clear about the widespread availability and use of coffee. There is a growing body of literature suggesting that coffee drinking can lower one’s risk of type II diabetes. This story covered the latest such evidence, and made it clear that this is part of a growing body of “more intriguing evidence.” There is no evidence that this story relied solely or largely on a news release.
[EX A]: Coffee found to reduce risk of diabetes

[EX Q]: A yoga, barre or spin class has become the new nine holes of golf, fitness experts said, chased by a post-workout smoothie rather than a three-martini lunch. “Sweatworking was born out of a desire to connect with clients on a deeper level that wasn’t so sales-y,” said Sarah Siciliano, 32, an advertising executive who has been entertaining clients with workouts. “A lot of sales jobs revolve around drinking.”   Siciliano, who is based in New York City, considers taking her mostly female clients, who range in age from 22 to 52, to yoga, spinning, bootcamp and dance studios a great tool to develop relationships. “People like to move along with the trends,” said Siciliano, who organizes her workout events. “I do all the leg work but I exercise everyday anyway so for me it’s a win-win,” she said. “If you can knock out a client event and your workout at the same time, why not?”  Sweatworking began in the advertising world, but has spread to more traditionally conservative professions such as law and banking, according to Alexia Brue, co-founder of the wellness media company Well+Good. “Now a lot of client entertaining in many industries has moved into boutique studios,” she said, “especially to those with workouts that aren’t super awkward, or super-sweaty to do with a client.”  Gabby Etrog Cohen, vice president of public relations and brand strategy at SoulCycle, a national chain of 39 indoor cycling studios, said in four years sweatworking has become a regular part of her business. “We get a mixed bag, a lot of people in financing and advertising,” said Cohen. “We have groups that come in every week. One group comes every Thursday.”  Part of the appeal, she speculates, resides in the dim studio lights. “There’s something about not wanting to sweat in front of clients,” she said. “We ride in the dark so there’s a sense of anonymity.”  For 45 minutes and $35 per class, the studio provides an alternative to the traditional four-hour round of golf. Cohen said the rise of sweatworking marks the distance traveled from the chain-smoking, inebriated lifestyle of the 1960’s portrayed in the hit AMC series “Mad Men.”  “We’ve taken ‘Mad Men’ and turned it on its head,” she said. (This version of the story corrects HBO to AMC in the second-to-last paragraph)
[EX A]:
Forget the martini lunch, sweatworking mixes business with exercise.